FOR IMMEDIATE RELEASE

ACS News Service Weekly PressPac: Wed Jun 22 16:42:03 EDT 2011

New delivery system for Viagra ingredient

Slow Release of NO by Microporous Titanosilicate ETS-4
Journal of the American Chemical Society

Scientists are reporting development and successful initial tests of a potential new delivery system for the biological signaling agent responsible for the effects of Viagra. It could be used to deliver the substance, called nitric oxide or NO, to treatment conditions ranging from heart disease to skin ulcers and other wounds that fail to heal, according to a report in the Journal of the American Chemical Society.

João Rocha and colleagues explain that NO acts as an important agent in the body for expanding blood vessels (its role in Viagra and related medicines for erectile dysfunction), preventing the formation of blood clots, aiding nerve signals, and repairing wounds. NO’s multipurpose role makes it an exciting prospect for new drug development, but current NO delivery systems sometimes cause undesirable side effects. “Clearly, new materials and technologies are needed to store and target-deliver NO in biological amounts,” the report notes.

The researchers developed a highly absorbent material that can carry varying amounts of NO. The material slowly releases NO at a rate that is useful for treating diseases, they conclude. More work must be done to calculate the “shelf life” of the material loaded with NO, Rocha and colleagues note, but they conclude: “This work is a first step toward assessing the real potential therapeutic applications of these materials.”

The authors acknowledge funding from the Fundo Europeu De Desenvolvimento Regional, Fundo Social Europeu, and the Fundaåão para a Ciência e a Tecnologia.

empty
Heart disease and certain other health problems
could be treated more effectively using a potential
new system for delivering nitric oxide, the substance
responsible for the effects of Viagra.

Contact

Science Inquiries: Michael Woods, Editor, 202-872-6293
General Inquiries
: Michael Bernstein, 202-872-6042